Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Dorman

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2008
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrationsKelly Dooley, Charles Flexner, Judith Hackman, et al.
Plos One|November 9, 2011
Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort studyMaunank Shah, Tafadzwa S Kasambira, Peter V Adrian, et al.
BMC Infectious Diseases|August 2, 2020
Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and CanadaMary R Reichler, Christina Hirsch, Yan Yuan, et al.
Plos One|December 25, 2013
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisAnna H van't Hoog, Frank Cobelens, Anna Vassall, et al.
BMC Public Health|May 14, 2008
Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective studyKathleen R Page, Yukari C Manabe, Akintoye Adelakun, et al.
BMC Public Health|September 2, 2014
Tuberculosis among health care workers in KwaZulu-Natal, South Africa: a retrospective cohort analysisCarrie Tudor, Martie Van der Walt, Bruce Margot, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailabilityRadojka M Savic, Yanhui Lu, Erin Bliven-Sizemore, et al.
The New England Journal of Medicine|November 14, 2003
The rapid development of fluoroquinolone resistance in M. tuberculosisAmy Sarah Ginsburg, Samuel C Woolwine, Nancy Hooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2016
Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South AfricaCarrie Tudor, Martie L Van der Walt, Bruce Margot, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2008
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrationsKelly Dooley, Charles Flexner, Judith Hackman, et al.
Plos One|November 9, 2011
Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort studyMaunank Shah, Tafadzwa S Kasambira, Peter V Adrian, et al.
BMC Infectious Diseases|August 2, 2020
Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and CanadaMary R Reichler, Christina Hirsch, Yan Yuan, et al.
Plos One|December 25, 2013
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisAnna H van't Hoog, Frank Cobelens, Anna Vassall, et al.
BMC Public Health|May 14, 2008
Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective studyKathleen R Page, Yukari C Manabe, Akintoye Adelakun, et al.
BMC Public Health|September 2, 2014
Tuberculosis among health care workers in KwaZulu-Natal, South Africa: a retrospective cohort analysisCarrie Tudor, Martie Van der Walt, Bruce Margot, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailabilityRadojka M Savic, Yanhui Lu, Erin Bliven-Sizemore, et al.
The New England Journal of Medicine|November 14, 2003
The rapid development of fluoroquinolone resistance in M. tuberculosisAmy Sarah Ginsburg, Samuel C Woolwine, Nancy Hooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2016
Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South AfricaCarrie Tudor, Martie L Van der Walt, Bruce Margot, et al.
Pageof 14